Founded Year
2003Stage
Acquired | AcquiredTotal Raised
$73.96MValuation
$0000About Ardian
Ardian is a developer of a catheter-based medical device to treat hypertension based in Mountain View, California. Ardian was founded by The Foundry, a medical device incubator based in Menlo Park, California. Ardians investors include Morgenthaler Ventures, Advanced Technology Ventures, Split Rock Partners, Medtronic and Emergent Medical Partners.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Ardian Patents
Ardian has filed 21 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/12/2013 | 7/22/2014 | Neurotechnology, Neurophysiology, Implants (medicine), Kidney diseases, Neuroscience | Grant |
Application Date | 2/12/2013 |
|---|---|
Grant Date | 7/22/2014 |
Title | |
Related Topics | Neurotechnology, Neurophysiology, Implants (medicine), Kidney diseases, Neuroscience |
Status | Grant |
Latest Ardian News
Sep 18, 2023
The general management team comprises five senior executives, including president Dominique Senequier. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@peimedia.com . Copyright PEI Media Share with other subscribers Cancel
Ardian Frequently Asked Questions (FAQ)
When was Ardian founded?
Ardian was founded in 2003.
Where is Ardian's headquarters?
Ardian's headquarters is located at 1380 Shorebird Way, Mountain View.
What is Ardian's latest funding round?
Ardian's latest funding round is Acquired.
How much did Ardian raise?
Ardian raised a total of $73.96M.
Who are the investors of Ardian?
Investors of Ardian include Medtronic, Morgenthaler Ventures, Advanced Technology Ventures, St. Paul Venture Capital, Split Rock Partners and 6 more.
Who are Ardian's competitors?
Competitors of Ardian include Endologix, OrthAlign, USGI Medical, Dune Medical Devices, Avantis Medical Systems and 13 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Ardian to Competitors
Tayside Flow Technologies Limited is a medical device company. It had developed the Spiral Laminar Flow Vascular Arteriovenous Graft.Tayside Flow Technologies Ltd (TFT) is a medical technology company focussed on the development of cardiovascular devices based on a new understanding of blood flow dynamics, Spiral Laminar Flow.
Verifica BG is a medical device making company.
Precision Light is a stealth-mode medical device company
CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.
MicroTransponder operates as a global medical device company. It develops research-based neuroscience solutions. The company focuses on restoring independence and dignity for people suffering from neurological conditions to impair sensory and motor function. MicroTransponder was founded in 2007 and is based in Austin, Texas.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
